Cover Image
Market Research Report

Asia Pacific Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class ; Action Mechanism ; and Country

Published by The Insight Partners Product code 943384
Published Content info 123 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class ; Action Mechanism ; and Country
Published: June 9, 2020 Content info: 123 Pages
Description

Title:
Asia Pacific Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country .

The Asia Pacific antibiotics market is expected to reach US$ 15,784.01 million by 2027 from US$ 11,591.97 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027.

The antibiotics market is growing primarily due to prevalence of infectious diseases and consolidated government initiatives in emerging economies of Asia Pacific region. Thetedious and expensive process of antibiotic development islikely to damage the growth of the market in the coming years. Additionally,growing investments to combat antimicrobial resistanceand incorporation of novel computing technologies for antibiotics discoveryare likely to increase the growth of the Antibioticsmarketduring the forecast period.

Antibiotics refer to a class of medicines containing substances that are active against bacteria. These medicines either kill the bacteria or control the infection by inhibiting the bacterial reproduction, which in turn helps patient to recover. Antibiotics are specific to the type of bacteria being treated and are not able to be interchanged from one infection to another.

Bacterial infection refers to the proliferation of harmful bacterial strains on or inside the human body. These microorganisms can infect any part of the body and may lead to severe consequences. A few of the indications of bacterial infections include pneumonia, meningitis, and food poisoning. Moreover, several of the commonly occurring pediatric bacterial infections are acute otitis media (AOM), sinusitis, bronchitis, upper respiratory tract infection, and pharyngitis.

The Asia Pacific region resides two-thirds of the world's population and is highly vulnerable to the threats of (antimicrobial resistance) AMR. The low and middle-income countries in Asia pacific region have major issues such as unplanned urbanization, poor sanitation environment, suboptimal wastewater management, and rising level of air pollutants causing respiratory problems often treated by the antibiotics. Patients in 10 hospitals across India with MDR and XDR bacteria were 1.57 times and 2.65 times more likely to die compared to similar susceptible infections. In Thailand, 19,122 of 45,209 (43%) deaths in nine hospitals across Thailand were attributed to healthcare-associated infections due to multi-drug resistance. Thus, the increasing prevalence of AMR is expected to continue to drive the growth of antibiotics market during the forecast period.

The prevalence of antimicrobial resistant bacteria is also increasing in developing as well as developed countries. For instance, according to a study published by Center for Disease Dynamics, Economics & Policy (CDDEP), in 2018, antibiotic-resistant infections cause ~700,000 deaths each year in low and middle-income economies. Thus, the increasing prevalence of such drug-resistant bacteria compels the manufacturers and R&D faculties to come up with new variants of effective antimicrobials against the new and old bacterial strains, thereby fueling the growth of the antibiotics market.

Considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19. Domestic startups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy. Additionally, the shift from antibiotics clinical trials to coronavirus trails is expected to have negative impact on introduction of new antibiotics, which in turn will slow down the growth of antibiotics market in the region.

In 2019, the cephalosporin segment accounted for the largest share of the market; it is further expected to continue its dominance duringthe forecast period. This class of antibiotics is usually safe due to low toxicity to self-cells and remarkable efficiency against susceptible bacteria. On the other hand, fluoroquinolones are expected to register the highest CAGR in the antibiotics market during 2020-2027.

Some of the significant secondary sources for antibioticsmarket included in the report are the World Health Organization (WHO), Central Drugs Standard Control Organisation (CDSCO),Center for Disease Dynamics, Economics & Policy (CDDEP),and others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Antibiotics Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the regional Antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00011393

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Antibiotics Market - By Drug Class
    • 1.3.2 Asia Pacific Antibiotics Market - By Action Mechanism
    • 1.3.3 Asia Pacific Antibiotics Market - By Country

2. Asia Pacific Antibiotics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Antibiotics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Antibiotics Market - Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia Pacific Antibiotics Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Bacterial Infections
    • 5.1.2 Consolidated Government Approach in Emerging Economies
  • 5.2 Key Market Restraints
    • 5.2.1 Tedious and Expensive Process of Antibiotic Development
  • 5.3 Market Opportunities
    • 5.3.1 Growing Investments to Combat Antimicrobial Resistance
  • 5.4 Future Trends
    • 5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
  • 5.5 Impact analysis

6. Antibiotics Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Antibiotics Market Revenue Forecasts and Analysis

7. Asia Pacific Antibiotics Market Analysis And Forecasts To 2027 - By Drug Class

  • 7.1 Overview
  • 7.2 Asia Pacific Antibiotics market, By Drug Class 2019 & 2027 (%)
    • 7.2.1 Asia Pacific Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
  • 7.3 Sulfonamides
    • 7.3.1 Overview
    • 7.3.2 Asia Pacific Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Aminoglycosides
    • 7.4.1 Overview
    • 7.4.2 Asia Pacific Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.5 Carbapenem
    • 7.5.1 Overview
    • 7.5.2 Asia Pacific Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.6 Macrolides
    • 7.6.1 Overview
    • 7.6.2 Asia Pacific Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.7 Fluoroquinolones
    • 7.7.1 Overview
    • 7.7.2 Asia Pacific Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.8 Penicillin
    • 7.8.1 Overview
    • 7.8.2 Asia Pacific Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.9 Cephalosporins
    • 7.9.1 Overview
    • 7.9.2 Asia Pacific Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Asia Pacific Antibiotics Market Analysis - By Action Mechanism

  • 8.1 Overview
  • 8.2 Asia Pacific Antibiotics Market, By Action Mechanism 2019-2027 (%)
    • 8.2.1 Asia Pacific Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)
  • 8.3 Mycolic Acid Inhibitors
    • 8.3.1 Overview
    • 8.3.2 Asia Pacific Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 RNA Synthesis Inhibitors
    • 8.4.1 Overview
    • 8.4.2 Asia Pacific RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 DNA Synthesis Inhibitors
    • 8.5.1 Overview
    • 8.5.2 Asia Pacific DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 Protein Synthesis Inhibitors
    • 8.6.1 Overview
    • 8.6.2 Asia Pacific Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.7 Cell Wall Synthesis Inhibitors
    • 8.7.1 Overview
    • 8.7.2 Asia Pacific Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Antibiotics Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 9.1 Asia Pacific Antibiotics Market Revenue and Forecasts To 2027
    • 9.1.1 Overview
    • 9.1.2 Asia Pacific: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 Asia Pacific: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
    • 9.1.4 Asia Pacific: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.5 Asia Pacific: Antibiotics Market, by Country, 2018 & 2027 (%)
    • 9.1.6 China: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 China: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 China: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.6.3 China: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.7 Japan: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Japan: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Japan: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.7.3 Japan: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.8 India: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 India: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 India: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.8.3 India: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.9 South Korea: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.9.1 South Korea: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.9.2 South Korea: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.9.3 South Korea: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.10 Australia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.10.1 Australia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.10.2 Australia: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.10.3 Australia: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)

10. Impact Of COVID-19 Pandemic on Asia Pacific Antibiotics Market

  • 10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11. Company Profiles

  • 11.1 GlaxoSmithKline plc.
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Sanofi
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Novartis AG
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Astellas Pharma Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Pfizer Inc.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About the Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
  • Table 2. Asia Pacific Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)
  • Table 3. Asia Pacific Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 4. Asia Pacific Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 5. China Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 6. China Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Japan Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Japan Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 9. India Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 10. India Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 11. South Korea Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 12. South Korea Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Australia Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Australia Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Glossary of Terms, Antibiotics Market

List Of Figures

  • Figure 1. Antibiotics Market Segmentation
  • Figure 2. Asia Pacific Antibiotics Market Overview
  • Figure 3. Cephalosporin Segment Held Largest Share of Product in Antibiotics Market
  • Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Asia Pacific Antibiotics Market - Leading Country Markets (US$ Mn)
  • Figure 6. Antibiotics Market - Asia Pacific PEST Analysis
  • Figure 7. Antibiotics market impact analysis of driver and restraints
  • Figure 8. Asia Pacific Antibiotics market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 9. Asia Pacific Antibiotics market, By Drug Class 2019 & 2027 (%)
  • Figure 10. Asia Pacific Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 11. Asia Pacific Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 12. Asia Pacific Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 13. Asia Pacific Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. Asia Pacific Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 15. Asia Pacific Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 16. Asia Pacific Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 17. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 18. Asia Pacific Antibiotics Market, by Action Mechanism 2019 & 2027 (%)
  • Figure 19. Asia Pacific Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. Asia Pacific RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Asia Pacific DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Asia Pacific Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Asia Pacific Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 24. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Asia Pacific: Antibiotics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 26. Asia Pacific Antibiotics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 27. China: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 28. Japan: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. India: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. South Korea: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Australia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 32. Impact of Covid-19 Pandemic in Asia-Pacific Country Markets
Back to Top